Publications by authors named "Federica Pilo"

Claim this Profile
R
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation.
Fabio Guolo, Luana Fianchi, Maria Paola Martelli, Federico Lussana, Francesco Grimaldi, Federica Pilo

Am J Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia.
Calogero Vetro, Bruno Garibaldi, Francesco Grimaldi, Patrizia Chiusolo, Carla Filì, Federica Pilo

Blood Cancer J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.
Raffaele Palmieri, Fabio Guolo, Luana Fianchi, Felicetto Ferrara, Paola Minetto, Federica Pilo

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia.
Calogero Vetro, Bruno Garibaldi, Francesco Grimaldi, Patrizia Chiusolo, Carla Filì, Federica Pilo

Blood Cancer J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unmet Needs and Their Impact on Quality of Life and Symptoms in Myelodysplastic Neoplasm Patients and Caregivers.
Elena Crisà, Daniela Cilloni, Marta Riva, Enrico Balleari, Daniela Barraco, Federica Pilo

Cancers (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of primary cancer history and molecular landscape in therapy-related myeloid neoplasms.
Alessandro Costa, Federica Pilo, Martina Pettinau, Eugenia Piras, Clara Targhetta

Front Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndrome.
Carmelo Gurnari, Elisa Galossi, Eleonora Lumia, Alfonso Piciocchi, Mariadomenica Divona, Federica Pilo

Br J Haematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEXAS syndrome: is it more a matter of inflammation or hematopoietic clonality? A case series approach to diagnosis, therapeutic strategies and transplant management.
Alessandro Costa, Federica Pilo, Martina Pettinau, Matteo Piga, Pietro Carboni

Ann Hematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vamifeport: Monography of the First Oral Ferroportin Inhibitor.
Federica Pilo, Emanuele Angelucci

J Clin Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort.
Carmelo Gurnari, Maria Rosaria Pascale, Antonio Vitale, Elisa Diral, Alessandro Tomelleri, Federica Pilo

Am J Hematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitapivat for sickle cell disease and thalassemia.
Federica Pilo, Emanuele Angelucci

Drugs Today (Barc)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron-mediated tissue damage in acquired ineffective erythropoiesis disease: It's more a matter of burden or more of exposure to toxic iron form?
Federica Pilo, Daniela Cilloni, Matteo Giovanni Della Porta, Gian Luca Forni, Alberto Piperno

Leuk Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perls Stain Grade in Bone Marrow Aspirate Correlates with Overall Survival in Low-Risk Myelodysplastic Patients.
Federica Pilo, Giovanni Caocci, Giannalisa Mele, Giorgio La Nasa

Acta Haematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience.
Sandra Mossuto, Enrico Attardi, Francesco Alesiani, Emanuele Angelucci, Enrico Balleari, Federica Pilo

Hemasphere· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis.
Enrico Balleari, Rosa Angela Filiberti, Chiara Salvetti, Bernardino Allione, Emanuele Angelucci, Federica Pilo

Cancer Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron Toxicity and Hemopoietic Cell Transplantation: Time to Change the Paradigm.
Federica Pilo, Emanuele Angelucci

Mediterr J Hematol Infect Dis· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron toxicity - Its effect on the bone marrow.
Alessandro Isidori, Lorenza Borin, Elena Elli, Roberto Latagliata, Bruno Martino, Federica Pilo

Blood Rev· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiogenic Shock during First Infusion of Anthracycline Chemotherapy in a Patient with Hodgkin Lymphoma: An Unusual Event.
Giulio Binaghi, Damiana Congia, Stefano Cossa, Stefania Massidda, Daniele Pasqualucci, Federica Pilo

Cardiology· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-transferrin-bound iron and oxidative stress during allogeneic hemopoietic stem cell transplantation in patients with or without iron overload.
Lorena Duca, Maria Domenica Cappellini, Donatella Baronciani, Federica Pilo, Clara Targhetta

Am J Hematol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A storm in the niche: Iron, oxidative stress and haemopoiesis.
Federica Pilo, Emanuele Angelucci

Blood Rev· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transplantation in thalassemia: Revisiting the Pesaro risk factors 25 years later.
Emanuele Angelucci, Federica Pilo, Thomas D Coates

Am J Hematol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelodysplastic Syndromes and Iron Chelation Therapy.
Emanuele Angelucci, Silvana Anna Maria Urru, Federica Pilo, Alberto Piperno

Mediterr J Hematol Infect Dis· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of iron overload before, during, and after hematopoietic stem cell transplantation for thalassemia major.
Emanuele Angelucci, Federica Pilo

Ann N Y Acad Sci· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolving clinical scenario of myelodysplastic syndrome: the need for a complete and up to date upfront diagnostic assessment.
Federica Pilo, Anna Angela Di Tucci, Paolo Dessalvi, Aldo Caddori, Emanuele Angelucci

Eur J Intern Med· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopietic stem cell transplantation in thalassemia and related disorders.
Emanuele Angelucci, Federica Pilo, Clara Targhetta, Martina Pettinau, Cristina Depau

Mediterr J Hematol Infect Dis· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis